Join us in welcoming Harry Kleanthous to the Apriori team as our Chief Scientific Officer. Harry's 30 years of experience and leadership at biotech and large biopharma companies will be a tremendous asset as we work to better protect humanity against rapidly-evolving viruses. Learn more about what he brings to our team: https://lnkd.in/e8e-c6GV #FlagshipFounded
Apriori Bio
Biotechnology
Apriori Bio is working to create a world where humanity is protected against viral threats.
About us
Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to survey the entire landscape of existing and potential viral variants to design new vaccines and antibody drugs against the most threatening variants. Octavia can also inform public health policy in real time by predicting the impact of emerging variants. Apriori was founded in 2020 in Flagship Labs, a unit of Flagship Pioneering.
- Website
-
aprioribio.com
External link for Apriori Bio
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Type
- Privately Held
Employees at Apriori Bio
Updates
-
Apriori President Craig Williams recently joined other global healthcare leaders on a panel at the UNGA Science Summit 2024 to discuss pandemic preparedness and the importance of data to improve decision-making and global health outcomes. Craig spoke about our work to help provide humanity with variant-resilient protection against rapidly-evolving viruses, and the need to invest in infrastructure now to prevent future pandemics. Thank you to Airfinity Ltd for organizing this important conversation. #SSUNGA79 #FlagshipFounded
-
-
We're pleased to welcome Seth Berkley, Arup Chakraborty, and Ashish Jha to our Board of Directors. These world-class vaccine, immunology, and public health leaders will join Board Chair Lovisa Afzelius and Travis Wilson, Growth Partner at Flagship Pioneering, in supporting our leadership team as they advance our mission to protect humanity against viral threats. Their expertise in vaccine development and public health will be instrumental as we expand our biology-informed AI platform, Octavia™, to develop variant-resilient protection against rapidly-evolving viruses. Read the full press release to learn more: https://lnkd.in/ePXt6s_r #FlagshipFounded
-
-
Citeline’s Eliza Slawther wrote about how Apriori is leading the way in vaccine development by leveraging AI and machine learning to design variant-resilient vaccines. Our CEO Lovisa Afzelius commented on the importance of shifting away from the reactive way in which vaccines have previously been developed and distributed. Read more about how we are using our platform Octavia™ to get ahead of future viral outbreaks: https://lnkd.in/ekYzn7zd
-
-
Proactively protecting health through preemptive medicine is a key pillar of our work at Apriori. We are excited to work with Raj Panjabi as he steps in to lead the Preemptive Health and Medicine Initiative at Flagship Pioneering. He has deep experience, both as a physician and serving in the Biden administration, tackling some of the world’s biggest public health challenges. His insights will help us develop variant-resilient vaccines to protect humanity against viral threats.
Flagship welcomes Raj Panjabi as Senior Partner to lead Flagship’s Preemptive Health and Medicine Initiative, which is pioneering a new field to protect, maintain, or improve people’s health before they get sick. Read the full announcement: https://bit.ly/4dz0Mxk
-
Members of our team and their families joined our CEO Lovisa Afzelius and president Craig Williams for a picnic to celebrate summer and our milestones this year. It was fun to connect outside of the office!
Last weekend, the teams at Apriori Bio, Metaphore Biotechnologies, Prologue Medicines, FL101, and FL104, along with families and friends, gathered for our inaugural summer picnic. Thank you all for joining. It was great to get to know those important to you and a fantastic opportunity to celebrate our progress and success while enjoying quality time together outside of work. #FlagshipFounded #BiggerLeaps
-
-
Today is an exciting day to be a #FlagshipFounded company as Flagship Pioneering announces a $3.6 billion fund to further transform human health. This commitment to innovation is the latest example of the bold scientific leaps we, and other companies across the ecosystem, are taking to advance scientific breakthroughs. For our part, we look forward to continuing our work to protect humanity against future viral threats and we look forward to seeing the new innovations supported by this fund.
Flagship Pioneering raises $3.6 billion to fuel critical breakthroughs in human health and sustainability. This expanded capital pool will accelerate the impact of original science and the creation and development of an estimated 25 breakthrough companies in human health, sustainability, and artificial intelligence. Hear from Flagship Founder and CEO Noubar Afeyan about how we're taking #BiggerLeaps by leveraging the power of generative AI, forging novel partnerships with pharma to speed drug development, expanding globally, and promoting and hiring top talent to our leadership ranks. Read the full press release: https://bit.ly/4eQfx05
-
We are pleased to announce that we have been awarded funding from CEPI (Coalition for Epidemic Preparedness Innovations), a global leader in pandemic preparedness, to help advance our biology-informed #artificialintelligence platform Octavia™. The insights we gather from Octavia will help to ensure the global community is better prepared to effectively address future outbreaks with precision and speed. Through this work, we aim to develop variant-resilient vaccines that remain protective for years to come, with an initial focus on further exploring pandemic influenza strain H3N2. Read more about how these funds will help advance our platform and our mission to protect humanity against future viral threats: https://lnkd.in/eX-Yrr47
-
-
We recently spoke with senior scientist Nicole Thadani, PhD, about her background and deep interest in human immunology, and how she learned about Apriori from the research of Apriori scientific advisor Jesse Bloom, PhD. “We’re at this pivotal moment where society has recognized how much pandemics can shape our lives. It’s a great time to take advantage of the investment society is willing to make to better prepare to address the next one,” she shared. Read our full Q&A with Nicole below. #AprioriLife #WeAreHiring #JoinUs
-
-
Last week, we partnered with Flagship Pioneering to convene leading scientists, regulators, and policymakers to discuss the future of variant-resilient vaccines. Many of the most threatening viruses are constantly evolving, outpacing efforts to chase them with new vaccines, which is why our team is working to get ahead of them. Thank you to our speakers for engaging in this important conversation about the regulatory landscape and policy solutions to help better protect humanity against viral threats. #FlagshipFounded
Many of the world’s viruses continue to evolve faster than medicines and vaccines can be developed to stop them. Instead of chasing viruses as they evolve, there is a shared need to get ahead of them. Last week, Flagship convened scientific leaders, regulators, and policymakers at the Wellcome Collection to discuss the future of 21st-century vaccines, the advances being made by scientists in academia and industry, and the regulation and policy changes that will enable innovation to thrive within the UK and spark bigger leaps globally.
-
-
-
-
-
1
-